Printer Friendly

Browse Cystinosis topic

 

Articles

1-41 out of 41 article(s)
Title Author Type Date Words
Diagnosis and monitoring of cystinosis using immunomagnetically purified granulocytes. Gertsman, Ilya; Johnson, Wynonna S.; Nishikawa, Connor; Gangoiti, Jon A.; Holmes, Bonnie; Barshop, B Report May 1, 2016 4399
New market study, "Cystinosis Global Clinical Trials Review, H2, 2015", has been published. Report Nov 6, 2015 508
New Report Available: Cystinosis Global Clinical Trials Review, H1, 2015. Mar 25, 2015 420
An interesting case of nephropathic cystinosis--Lignac Fanonis syndrome. Ganagi, Srinivas M.; Budihal, Shivaraj Clinical report Aug 7, 2014 1545
Raptor Pharmaceutical Corp awarded marketing approval for PROCYSBI for proven nephropathic cystinosis in the EU. Sep 13, 2013 269
Raptor Pharmaceutical Corp awarded marketing approval for PROCYSBI for proven nephropathic cystinosis in the EU. Sep 13, 2013 265
Raptor Pharmaceutical Corp receives EMA's positive opinion for orphan drug exclusivity for nephropathic cystinosis drug, PROCYSBI. Jul 23, 2013 215
Raptor Pharmaceutical Corp receives EMA's positive opinion for orphan drug exclusivity for nephropathic cystinosis drug, PROCYSBI. Jul 23, 2013 211
Raptor Pharmaceutical Corp awarded US orphan drug exclusivity for PROCYSBI for nephropathic cystinosis. Jun 26, 2013 193
Raptor Pharmaceutical Corp awarded US orphan drug exclusivity for PROCYSBI for nephropathic cystinosis. Jun 26, 2013 179
Raptor's PROCYSBI approved by US FDA for treatment of Nephropathic Cystinosis. May 2, 2013 217
Raptor's PROCYSBI approved by US FDA for treatment of Nephropathic Cystinosis. May 2, 2013 203
Multimedia Now Available: Raptor Pharmaceutical's PROCYSBI(TM) Receives FDA Approval for the Treatment of Nephropathic Cystinosis. May 1, 2013 1660
Raptor Pharmaceutical's PROCYSBI(TM) Receives FDA Approval for the Treatment of Nephropathic Cystinosis. Apr 30, 2013 1625
Raptor Pharmaceutical's PROCYSBI(TM) Receives FDA Approval for the Treatment of Nephropathic Cystinosis. Apr 30, 2013 1617
Cystinosis Community Takes Capitol Hill with Unified Voice for Rare Disease. Jan 28, 2013 992
Raptor Pharmaceutical Corp announces acceptance of NDA by FDA for RP103 for the potential treatment of nephropathic cystinosis. Jun 14, 2012 209
Raptor Pharmaceutical Corp submits NDA to FDA to market RP103 for nephropathic cystinosis. Apr 2, 2012 197
Raptor Pharmaceutical Corp receives EMA validation of MAA for RP103 for Nephropathic Cystinosis. Mar 27, 2012 208
Raptor gives update on Phase III study of DR Cysteamine for nephropathic cystinosis. Jun 8, 2011 335
Raptor completes enrollment in Phase III trial of DR Cysteamine in cystinosis. Jan 25, 2011 220
Raptor Pharmaceutical Corp. to Present Cystinosis Research at Lysosomal Disease Network's 2010 WORLD Symposium; - Forms European Subsidiary, Raptor Pharmaceuticals Europe BV. Feb 10, 2010 1268
Raptor Pharmaceutical Corp. Announces Publication of Results from Phase 2a Trial of DR Cysteamine for Treatment of Cystinosis; - Potential to Improve Treatment with Less Frequent Administration and Better Tolerability. Jan 11, 2010 1468
Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis. Nov 23, 2009 1417
Raptor completes Phase IIb study of DR Cysteamine in cystinosis. Clinical report Nov 23, 2009 255
Jason Grier Elected To Board Of Cystinosis Research Foundation. Jun 16, 2009 469
Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis. Jun 1, 2009 1283
$2.3 Million Raised for Cystinosis Research. Jun 1, 2009 531
Cystinosis Research Foundation Donor Issues Unprecedented $1-Million Challenge Grant. Apr 9, 2009 442
Company Profile for Cystinosis Research Foundation. Company overview Apr 9, 2009 128
Cystinosis Research Foundation Grants $425,528 to Researchers and Scientists in U.S., Europe for Rare Disease Studies. Feb 12, 2009 582
Cystinosis Research Foundation Funds Researchers in U.S., Europe with $425,528 to Unlock Mysteries of Rare Disease. Feb 9, 2009 585
Bestselling Author Mitch Albom To Be Featured Speaker At Annual Natalie's Wish Fundraiser For Cystinosis In Newport Beach. Jan 12, 2009 656
Second Annual 'Fore A Cure' Golf Tournament Raises $225,000 to Fund Cystinosis Research. Nov 21, 2008 323
Cystinosis Research Foundation Revamps Website, Improves Channel for Donations and Research News. Oct 13, 2008 358
Scientific Abstracts On Cystinosis Research Are Published In October Issue of Pediatric Nephrology. Sep 18, 2008 838
Cystinosis Research Foundation Funds Nine Studies Totaling $1.3 Million in U.S., Europe to Solve Mysteries of Rare Disease. Aug 4, 2008 891
Raptor Pharmaceuticals Corp. Announces Presentation at 5th International Cystinosis Conference 2008. Jun 23, 2008 1374
Behavior in children with a chronic illness: a descriptive study of child characteristics, family adjustment, and school issues in children with cystinosis. Spilkin, Amy; Ballantyne, Angela Mar 1, 2007 9103
Comparison of cystine determination in mixed leukocytes vs polymorphonuclear leukocytes for diagnosis of cystinosis and monitoring of cysteamine therapy. Levtchenko, Elena; de Graaf-Hess, Adriana; Wilmer, Martijn; van den Heuvel, Lambertus; Monnens, Leo; Sep 1, 2004 1667
THE CYSTINOSIS FOUNDATION. Oct 1, 2000 647

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters